Academic Journal
Practice, knowledge and attitude of physicians and pharmacists towards the spontaneous reporting system of adverse drug reactions in Switzerland.
| Title: | Practice, knowledge and attitude of physicians and pharmacists towards the spontaneous reporting system of adverse drug reactions in Switzerland. |
|---|---|
| Authors: | Strobel FA; Faculty for Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland., Stammschulte T; Pharmacovigilance, Safety of Medicines Division, Swissmedic, Swiss Agency for Therapeutic Products, Berne, Switzerland., Beeler PE; Faculty for Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland.; Center for Clinical Research, Lucerne Cantonal Hospital/University of Lucerne, Lucerne, Switzerland. |
| Source: | British journal of clinical pharmacology [Br J Clin Pharmacol] 2026 Aug; Vol. 92 (8), pp. 2797-2808. Date of Electronic Publication: 2026 Apr 17. |
| Publication Type: | Journal Article |
| Language: | English |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE |
| Imprint Name(s): | Publication: Oxford : Wiley-Blackwell Original Publication: London, Macmillan Journals Ltd. |
| MeSH Terms: | Adverse Drug Reaction Reporting Systems*/statistics & numerical data , Pharmacists*/statistics & numerical data , Pharmacists*/psychology , Physicians*/statistics & numerical data , Physicians*/psychology , Drug-Related Side Effects and Adverse Reactions*/epidemiology , Health Knowledge, Attitudes, Practice* , Attitude of Health Personnel*, Humans ; Switzerland ; Male ; Female ; Cross-Sectional Studies ; Adult ; Middle Aged ; Surveys and Questionnaires ; Pharmacovigilance ; Aged ; Young Adult |
| Abstract: | Introduction: Reporting adverse drug reactions (ADRs) is essential for detecting drug risks. Despite legal obligations in Switzerland, underreporting remains an issue. This study assessed practice, knowledge and attitudes towards the spontaneous ADR reporting system among physicians and pharmacists. Methods: A nationwide cross-sectional survey was disseminated via professional associations to physicians and pharmacists in Switzerland. The 21-item questionnaire assessed reporting practice, knowledge, attitudes, information needs and improvement suggestions. Multivariable regression (odds ratios [ORs], 95% confidence intervals [95% CIs]) examined associations between participant characteristics and reporting habits. Results: A total of 1108 participants (834 physicians, 274 pharmacists) were included. ADRs had been suspected by 589 (53.2%), and 562 (50.7%) had reported ≥1 ADR. Most participants rejected the notion that reporting is pointless (999, 90.2%). Although 716 (64.6%) were aware of reporting obligations, 477 (43.1%) perceived reporting as time-consuming and 270 (24.4%) reported legal concerns. About half indicated no lack of incentives (587, 53.0%) and no concerns regarding personal (580, 52.3%) or patient data protection (545, 49.2%). More than half desired clearer guidance on reportable ADRs (609, 55.0%) and 648 (58.5%) expressed interest in pharmacovigilance training. Reporting ADRs was independently associated with increasing age and training (ORs between 1.28 [95% CI: 1.15, 1.42] and 1.92 [1.32, 2.79]), whereas investing >10 min in reporting was associated with age ≥60 (OR 1.59 [1.07, 2.38]), training (OR 1.28 [1.14, 1.45]) and pharmacist status (OR 1.83 [1.34, 2.51]). Conclusion: The fundamental willingness to report ADRs despite a simultaneous lack of specific knowledge indicates a need for targeted information campaigns and training opportunities. (© 2026 The Author(s). British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society.) |
| References: | Wester K, Jönsson AK, Spigset O, Druid H, Hägg S. Incidence of fatal adverse drug reactions: a population based study. Brit J Clinical Pharma. 2008 Apr;65(4):573‐579. doi:10.1111/j.1365‐2125.2007.03064.x. D Rottenkolber, S Schmiedl, M Rottenkolber, K Farker, K Saljé, S Mueller, Hippius M., Thuermann P.A., Hasford J., for the Net of Regional Pharmacovigilance Centers M. Hippius, P.A. Thuermann, J. Hasford, for the Net of Regional Pharmacovigilance Centers. Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations. Pharmacoepidemiol Drug 2011 Jun;20(6):626–634. 10.1002/pds.2118. Sultana J, Cutroneo P, Trifirò G. Clinical and economic burden of adverse drug reactions. J Pharmacol Pharmacother. 2013;4(1_suppl):S73‐S77. doi:10.4103/0976‐500X.120957. Wasserfallen JB, Livio F, Buclin T, Tillet L, Yersin B, Biollaz J. Rate, type, and cost of adverse drug reactions in emergency department admissions. Eur J Intern Med. 2001 Sep;12(5):442‐447. doi:10.1016/S0953‐6205(01)00159‐5. Montané E, Santesmases J. Adverse drug reactions. Med Clín (English Edition). 2020 Mar;154(5):178‐184. doi:10.1016/j.medcle.2019.08.005. Angamo MT, Chalmers L, Curtain CM, Bereznicki LRE. Adverse‐drug‐reaction‐related hospitalisations in developed and developing countries: a review of prevalence and contributing factors. Drug Saf. 2016 Sep;39(9):847‐857. doi:10.1007/s40264‐016‐0444‐7. Swissmedic © Copyright. Pharmacovigilance [Internet]. 2019 [cited 2024 Jan 19]. Available from: https://www.swissmedic.ch/swissmedic/en/home/humanarzneimittel/marktueberwachung/pharmacovigilance.html. World Health Organization. Regulation and prequalification [Internet]. 2024 [cited 2024 Mar 19]. Pharmacovigilance. Available from: https://www.who.int/teams/regulation‐prequalification/regulation‐and‐safety/pharmacovigilance. Swissmedic 2019 © Copyright. Meldung von vermuteten unerwünschten Arzneimittelwirkungen durch Patientinnen und Patienten [Internet]. [cited 2024 Jan 3]. Available from: https://www.swissmedic.ch/swissmedic/de/home/humanarzneimittel/marktueberwachung/pharmacovigilance/patienten-innen.html. SR 812.21. Federal Act on Medicinal Products and Medical Devices (Therapeutic Products Act, TPA) Interne 2000 Dec [cited 2024 Jan 12]. p. 36. Report No. Available from: https://www.fedlex.admin.ch/eli/cc/2001/422/de. Swissmedic 2019 © Copyright. Meldung von unerwünschten Arzneimittelwirkungen für medizinische Fachpersonen [Internet]. [cited 2024 Jan 3]. Available from: https://www.swissmedic.ch/swissmedic/de/home/humanarzneimittel/marktueberwachung/pharmacovigilance/elvis.html. Powell JF, Henneh IT, Ekor M. Knowledge, attitude and practice of physicians and nurses at the Cape Coast teaching Hospital in the Central Region of Ghana on spontaneous adverse drug reaction reporting. PLoS ONE. 2023;18(7):e0288100. doi:10.1371/journal.pone.0288100. Hazell L, Shakir SAW. Under‐reporting of adverse drug reactions: a systematic review. Drug Saf. 2006;29(5):385‐396. doi:10.2165/00002018‐200629050‐00003. Beeler PE, Stammschulte T, Dressel H. Hospitalisations related to adverse drug reactions in Switzerland in 2012–2019: characteristics, in‐hospital mortality, and spontaneous reporting rate. Drug Saf. 2023 Aug;46(8):753‐763. doi:10.1007/s40264‐023‐01319‐y. Varallo FR, Guimarães SDOP, Abjaude SAR, Mastroianni PDC. Causes for the underreporting of adverse drug events by health professionals: a systematic review. Rev Esc Enferm USP. 2014;48(4):739‐747. doi:10.1590/S0080‐623420140000400023. Bahlol M, Bushell M, Khojah HMJ, Dewey RS. Spontaneous adverse drug reaction reporting by community pharmacists: preparedness and barriers. Saudi Pharm J. 2022 Jul;30(7):1052‐1059. doi:10.1016/j.jsps.2022.04.006. Lopez‐Gonzalez E, Herdeiro MT, Figueiras A. Determinants of under‐reporting of adverse drug reactions: a systematic review. Drug Saf. 2009;32(1):19‐31. doi:10.2165/00002018‐200932010‐00002. Le TT, Nguyen TTH, Nguyen C, et al. Factors associated with spontaneous adverse drug reaction reporting among healthcare professionals in Vietnam. J Clin Pharm Ther. 2020;45(1):122‐127. doi:10.1111/jcpt.13037. Figueiras A, Herdeiro MT, Polónia J, Gestal‐Otero JJ. An educational intervention to improve physician reporting of adverse drug reactions: a cluster‐randomized controlled trial. Jama. 2006;296(6):1086. doi:10.1001/jama.296.9.1086. Patel NS, Patel TK, Patel PB, Naik VN, Tripathi C. Hospitalizations due to preventable adverse reactions—a systematic review. Eur J Clin Pharmacol. 2017 Apr;73(4):385‐398. doi:10.1007/s00228‐016‐2170‐6. A Sharma, NT Minh Duc, T Luu Lam Thang, NH Nam, SJ Ng, KS Abbas, Huy NT, Marušić A, Paul CL, Kwok J, Karbwang J, de Waure C, Drummond FJ, Kizawa Y, Taal E, Vermeulen J, Lee GHM, Gyedu A, To KG, Verra ML, Jacqz‐Aigrain ÉM, Leclercq WKG, Salminen ST, Sherbourne CD, Mintzes B, Lozano S, Tran US, Matsui M, Karamouzian M NT Huy, A Marušić, CL Paul, J Kwok, J Karbwang, C de Waure, FJ Drummond, Y Kizawa, E Taal, J Vermeulen, GHM Lee, A Gyedu, KG To, ML Verra, ÉM Jacqz‐Aigrain, WKG Leclercq, ST Salminen, CD Sherbourne, B Mintzes, S Lozano, US Tran, M Matsui, M Karamouzian A consensus‐based checklist for reporting of survey studies (CROSS). J Gen Intern Med 2021 Oct;36:3179–3187. 10.1007/s11606‐021‐06737‐1, 10. Oshikoya KA, Awobusuyi JO. Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria. BMC Clin Pharmacol. 2009;9(1):14. doi:10.1186/1472‐6904‐9‐14. Ahmad A, Patel I, Balkrishnan R, Mohanta G, Manna P. An evaluation of knowledge, attitude and practice of Indian pharmacists towards adverse drug reaction reporting: a pilot study. Perspect Clin Res. 2013;4(4):204‐210. doi:10.4103/2229‐3485.120168. Stammschulte T, Litwa M, Köberle U, et al. What German physicians think about the spontaneous reporting system and how they would change it. Results of an online survey. Drug Commission of the German Medical Association; 2018. Report No. Bundesamt für Statistik. Ständige und nichtständige Wohnbevölkerung nach Sprachgebiet, Staatsangehörigkeit (Kategorie), Geschlecht und Alter [Internet]. 2025. [cited 2025 Jul 15]. Available from: https://stats.swiss/vis?lc=de&df[ds]=disseminate&df[id]=DF_STATPOP_REGLING&df[ag]=CH1.STATPOP&df[vs]=1.0.0&dq=.1%2B2%2B3%2B4._T._T._T.A&lom=LASTNPERIODS&lo=1&to[TIME_PERIOD]=false. Schweizerischer Apothekerverband. Fakten und Zahlen Schweizer Apotheken [Internet]. Bern: pharmaSuisse; 2023 [cited 2024 Apr 7]. p. 31. Report No Available from: https://pharmasuisse.org/system/files/media/documents/2023‐11/A6_de_Fakten_Zahlen_2023_web.pdf. S Hostetter, E Kraft. FMH‐Ärztestatistik 2023—40% ausländische Ärztinnen und Ärzte [FMH‐Ärztestatistik] [Internet]. FMH; 2024 [cited 2024 Apr 7]. p. 32–6. (Schweizerische Ärztezeitung). Report No.: 105(12). Available from: https://www.fmh.ch/files/pdf30/1377245206‐de‐fmh‐‐‐aerztestatistik_0001‐1.pdf. Michaud P, Jucker‐Kupper P, members of the Profiles working group. PROFILES; principal objectives and framework for integrated learning and education in Switzerland. Joint Commission of the Swiss Medical Schools; 2017. C Berendonk, TEE Waldvogel, R Bonvin, C Schirlo, J Goldhahn, Z Frank, Nendaz M M Nendaz Revision of a nationwide competency framework for undergraduate medical education in Switzerland: PROFILES 2. Swiss Med Wkly 2025;155(9):4389. 10.57187/s.4389. Swissmedic. Meldung von unerwünschten Wirkungen [Internet]. 2024 [cited 2025 Jul 16]. Available from: https://www.swissmedic.ch/swissmedic/de/home/ueber‐uns/publikationen/video/meldung‐uaw.html. Costa C, Abeijon P, Rodrigues DA, Figueiras A, Herdeiro MT, Torre C. Factors associated with underreporting of adverse drug reactions by patients: a systematic review. Int J Clin Pharmacol. 2023 Dec;45(6):1349‐1358. doi:10.1007/s11096‐023‐01592‐y. D Kopciuch, T Zaprutko, A Paczkowska, P Ratajczak, Ł Zielińska‐Tomczak, K Kus, Nowakowska E E Nowakowska Safety of medicines—pharmacists' knowledge, practice, and attitudes toward pharmacovigilance and adverse drug reactions reporting process. Pharmacoepidemiol Drug 2019 Dec;28:1543–1551. 10.1002/pds.4792, 12. Hughes ML, Weiss M. Adverse drug reaction reporting by community pharmacists—the barriers and facilitators. Pharmacoepidemiol Drug. 2019 Dec;28(12):1552‐1559. doi:10.1002/pds.4800. Eland B, Van Grootheest M, Rawlins S. Attitudinal survey of voluntary reporting of adverse drug reactions. Br J Clin Pharmacol. 1999 Oct;48(4):623‐627. doi:10.1046/j.1365‐2125.1999.00060.x. Hasford J, Goettler M, Munter KH, Müller‐Oerlinghausen B. Physicians' knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions. J Clin Epidemiol. 2002 Sep;55(9):945‐950. doi:10.1016/S0895‐4356(02)00450‐X. García‐Abeijon P, Costa C, Taracido M, Herdeiro MT, Torre C, Figueiras A. Factors associated with underreporting of adverse drug reactions by health care professionals: a systematic review update. Drug Saf. 2023 Jul;46(7):625‐636. doi:10.1007/s40264‐023‐01302‐7. Oosterhuis I, Van Hunsel FPAM, Van Puijenbroek EP. Expectations for feedback in adverse drug reporting by healthcare professionals in the Netherlands. Drug Saf. 2011. doi:10.2165/11594910‐000000000‐00000. Green CF, Mottram DR, Rowe PH, Pirmohamed M. Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting. Brit J Clinical Pharma. 2001 Jan;51(1):81‐86. doi:10.1046/j.1365‐2125.2001.01306.x. World Health Organization. Safety of medicines—adverse drug reactions [Briefing Note]. p. 1–3. Report No. Thakkar S, Slikker W, Yiannas F, et al. Artificial intelligence and real‐world data for drug and food safety—a regulatory science perspective. Regul Toxicol Pharmacol. 2023;140:105388. doi:10.1016/j.yrtph.2023.105388. Shrestha S, Sharma S, Bhasima R, Kunwor P, Adhikari B, Sapkota B. Impact of an educational intervention on pharmacovigilance knowledge and attitudes among health professionals in a Nepal cancer hospital. BMC Med Educ. 2020 Dec;20(1):179. doi:10.1186/s12909‐020‐02084‐7. Ganesan S, Sandhiya S, Reddy K, Adithan C. The impact of the educational intervention on knowledge, attitude, and practice of pharmacovigilance toward adverse drug reactions reporting among health‐care professionals in a tertiary care hospital in South India. J Nat Sci Biol Med. 2017;8(2):203‐209. doi:10.4103/0976‐9668.210014. Weber GA, Bartel S, Boch M, et al. Increasing the reporting of adverse drug reaction‐related hospitalizations using an ICD‐10‐based identification workflow: a multicenter study from Switzerland. Br J Clin Pharmacol. 2026. doi:10.1002/bcp.70564. Mardani A, Griffiths P, Vaismoradi M. The role of the nurse in the management of medicines during transitional care: a systematic review. J Multidiscip Healthc. 2020;13:1347‐1361. doi:10.2147/JMDH.S276061. |
| Contributed Indexing: | Keywords: Switzerland; adverse drug reactions; pharmacists; pharmacovigilance; physicians; spontaneous reporting system; underreporting |
| Entry Date(s): | Date Created: 20260418 Date Completed: 20260729 Latest Revision: 20260801 |
| Update Code: | 20260801 |
| PubMed Central ID: | PMC13421059 |
| DOI: | 10.1002/bcp.70543 |
| PMID: | 41998847 |
| Database: | MEDLINE |
Be the first to leave a comment!